All News #Library
Quality
FDA Warns of Potential Cancer Risk With Weight Loss Drug
14 Jan 2020 //
RAPS
OPDP Enforcement Letters in 2018: Numbers Remain Low
11 Jan 2019 //
RAPS
NICE rejects Eisai`s Halaven in earlier setting for metastatic breast cancer
21 Feb 2018 //
PHARMAFILE
FDA delivers Form 483 to Eisai plant in U.S.
25 Jan 2017 //
FIERCE PHARMA
Eisai: FDA confirms enough data to move Alzheimer`s drug to Phase III studies
10 Aug 2016 //
REUTERS

Market Place
Sourcing Support